Introduction: Glaucoma and the Importance of Timely Treatment
Glaucoma is a chronic, progressive eye disease that is one of the leading causes of irreversible blindness worldwide [4]. Its key characteristic is damage to the optic nerve, often associated with elevated intraocular pressure (IOP). The only proven way to prevent further optic nerve damage and preserve vision is to effectively lower IOP [4]. Modern ophthalmology offers a wide range of glaucoma treatment methods that are constantly evolving, covering both pharmacological and surgical approaches.
Pharmacological Therapy: The Foundation of IOP Control
Although our article focuses on surgical methods, it is important to note that pharmacotherapy remains the cornerstone of glaucoma treatment [4]. In recent years, there has been a significant shift toward the use of prostaglandin analogs (PGAs) as first-line agents [4]. This is due to their high efficacy, convenience of use (usually once daily), better control of diurnal IOP fluctuations, and a favorable systemic safety profile compared to traditional beta-blockers [4]. However, one of the main obstacles to successful long-term glaucoma control is patient adherence to regular, lifelong use of eye drops [5]. This drives the search for new approaches, including innovative drug delivery systems that can provide long-term action and reduce dependence on daily administration [5].
Laser Methods: Fast, Effective, and Safe
Laser technologies hold an important place in the ophthalmologist's arsenal, offering fast, relatively painless, and well-tolerated procedures [1]. In glaucoma treatment, selective laser trabeculoplasty (SLT) has gained particular importance.
SLT is increasingly used as a first-line treatment for glaucoma [7, 8]. Clinical studies have shown that strategies starting with SLT provide IOP control comparable to medical therapy while significantly reducing the patient burden associated with constant eye drop use [7]. For example, in the LiGHT (Laser in Glaucoma and Ocular Hypertension Trial) study, approximately 70% of patients initially treated with SLT remained free of topical therapy and incisional surgery for 6 years [7]. Further analysis showed lower rates of moderate or rapid progression of visual field defects in the SLT group compared to the group that started treatment with medication (approximately 17% vs. 26%) [7]. Repeat SLT also demonstrates IOP reduction similar to the initial procedure without an increase in side effects [7].
From an economic perspective, SLT also shows advantages. A cost-effectiveness analysis in Canada showed that patients treated with SLT had lower costs for the healthcare system and a higher number of quality-adjusted life years compared to medical treatment [8]. This makes SLT not only an effective but also a cost-efficient option.
Minimally Invasive Glaucoma Surgery (MIGS): The Future of Surgery
The development of minimally invasive glaucoma surgery (MIGS) has been a significant breakthrough, offering improved risk-benefit profiles and more stable IOP control [5]. These procedures aim to lower intraocular pressure with less trauma to the eye compared to traditional filtering surgeries.
Innovations in the field of MIGS are driven by the need to overcome barriers related to patient adherence to lifelong eye drop use [5]. Currently, various new MIGS devices are being actively developed and tested in clinical trials, promising to provide sustained IOP control [5]. These methods expand treatment options, allowing the physician to individualize the approach for each patient, choosing the most appropriate strategy based on their individual needs and disease characteristics [5].
Evolution of Surgical Approaches and Innovations
In addition to MIGS, traditional surgical methods also continue to improve. Although they are typically used in more complex cases or when other methods are ineffective, understanding the pathogenesis of conditions such as malignant glaucoma (a rare and severe form that does not respond to traditional therapy) helps develop more targeted surgical interventions aimed at correcting the obstruction of normal aqueous humor outflow [6].
The future of glaucoma treatment also includes the development of new drug delivery systems that can provide sustained release of active substances, reducing the need for daily eye drops [5]. These innovations, along with the development of new MIGS devices, promise to significantly expand therapeutic options for patients with glaucoma [5].
Changes in Care Delivery: Lessons from the Pandemic
The COVID-19 pandemic also made adjustments to the delivery of ophthalmic care, including glaucoma treatment [2]. Many changes aimed at strengthening infection control measures and increasing efficiency are likely to persist after the pandemic [2]. A hybrid model of care has developed, involving diagnostic testing performed by technicians, followed by a virtual consultation with a glaucoma specialist [2]. This model has become a useful addition to traditional in-person visits, demonstrating the adaptability of specialists, patients, and staff to the "new normal" in glaucoma management [2].
Conclusion
Modern glaucoma treatment is a dynamically developing field, offering increasingly effective and safe methods for preserving vision. From innovative medications and laser procedures to advanced surgical interventions such as MIGS and new drug delivery systems, the options for controlling the disease are constantly expanding. It is important to undergo regular examinations and follow your doctor's recommendations to choose the optimal treatment strategy.
Sources
- Current uses of ophthalmic lasers.
- How glaucoma care changed for the better after the pandemic.
- Prostaglandin analogs in ophthalmology.
- Current opinion in ophthalmology: novel glaucoma devices in the pipeline.
- Malignant glaucoma.
- Beyond the Bottle: Lessons From the Laser in Glaucoma and Ocular Hypertension Trial.
- A cost-effectiveness analysis of medications compared with selective laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.
Disclaimer: The information provided in this article is for reference purposes only and should not be used for self-diagnosis or self-treatment. Always consult a qualified physician for an accurate diagnosis and an individualized treatment plan.